Latest filing published 09 Nov 2006 for Armata Pharmaceuticals, Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Biogen Idec Inc: trading record in brief
Biogen Idec Inc discloses dealings in 2 companies, chiefly Viracta Therapeutics, Inc. and Armata Pharmaceuticals, Inc. The record holds 4 filings, for trades running from 27 September 2005 to 7 November 2006.
The open-market record is one-sided, with 1 purchase worth €4.1M and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 1 share grant. 2006 to date brings 1 purchase and no sales.
On 9 November 2006 came the latest disclosure, a share grant in Armata Pharmaceuticals, Inc. The most recent open-market purchase was published on 14 February 2006, 7,573 days ago. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Biogen Idec Inc
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,000,000 sharesCommon Stock, $0.01 Par ValueSEC:0001209191-06-058620:0
- 659,321 shares0Common StockSEC:0001209191-06-010171:0
- 1,538,415 shares0Common StockSEC:0001209191-06-010171:1
- 714,286 shares@ US$7.00Common StockSEC:0001209191-06-010171:2Canonical exit: 26 Dec 2005 (T+90)
4 of 4 declarations
